Carlos E. Durán

1.1k total citations
23 papers, 466 citations indexed

About

Carlos E. Durán is a scholar working on Economics and Econometrics, Epidemiology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Carlos E. Durán has authored 23 papers receiving a total of 466 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Economics and Econometrics, 5 papers in Epidemiology and 4 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Carlos E. Durán's work include Health Systems, Economic Evaluations, Quality of Life (9 papers), Pharmaceutical Economics and Policy (7 papers) and Pharmaceutical Practices and Patient Outcomes (4 papers). Carlos E. Durán is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (9 papers), Pharmaceutical Economics and Policy (7 papers) and Pharmaceutical Practices and Patient Outcomes (4 papers). Carlos E. Durán collaborates with scholars based in Belgium, Netherlands and Ecuador. Carlos E. Durán's co-authors include Robert Vander Stichele, Majda Azermai, Thierry Christiaens, Monique Elseviers, José A. Oteo, Ángela Acosta, Gabriel J. Tobón, Juan Carlos Bravo, Miriam Sturkenboom and Carlos A. Cañas and has published in prestigious journals such as PLoS ONE, International Journal of Environmental Research and Public Health and Drug Safety.

In The Last Decade

Carlos E. Durán

20 papers receiving 454 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Carlos E. Durán Belgium	10	224	140	101	97	67	23	466
Maria Dolores Nieto‐Martín Spain	11	204 0.9×	79 0.6×	81 0.8×	38 0.4×	35 0.5×	31	389
Amanda J. Cross Australia	14	372 1.7×	124 0.9×	144 1.4×	42 0.4×	112 1.7×	44	654
Carla Meyer‐Massetti Switzerland	10	226 1.0×	80 0.6×	62 0.6×	50 0.5×	41 0.6×	46	524
Anne Spinewine Belgium	13	297 1.3×	197 1.4×	176 1.7×	26 0.3×	29 0.4×	32	530
Denis Curtin Ireland	11	485 2.2×	104 0.7×	267 2.6×	38 0.4×	57 0.9×	25	622
Kathryn E. Callahan United States	13	302 1.3×	74 0.5×	125 1.2×	28 0.3×	60 0.9×	58	645
Chelsea E. Hawley United States	14	162 0.7×	58 0.4×	118 1.2×	14 0.1×	27 0.4×	36	587
Teodoro J. Oscanoa Peru	9	224 1.0×	57 0.4×	80 0.8×	13 0.1×	28 0.4×	63	493
Nicole Vogt-Ferrier Switzerland	11	226 1.0×	46 0.3×	130 1.3×	16 0.2×	59 0.9×	24	547
Richard S Slavik Canada	14	105 0.5×	121 0.9×	37 0.4×	31 0.3×	7 0.1×	31	531

Countries citing papers authored by Carlos E. Durán

Since Specialization

Citations

This map shows the geographic impact of Carlos E. Durán's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carlos E. Durán with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carlos E. Durán more than expected).

Fields of papers citing papers by Carlos E. Durán

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carlos E. Durán. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carlos E. Durán. The network helps show where Carlos E. Durán may publish in the future.

Co-authorship network of co-authors of Carlos E. Durán

This figure shows the co-authorship network connecting the top 25 collaborators of Carlos E. Durán. A scholar is included among the top collaborators of Carlos E. Durán based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carlos E. Durán. Carlos E. Durán is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Pereira, Leonardo, Malede Mequanent Sisay, Carlos E. Durán, et al.. (2025). Comparison of Adverse Events in Pregnant Persons Receiving COVID-19 and Influenza Vaccines: A Disproportionality Analysis Using Combined Data from US VAERS and EudraVigilance Spontaneous Report Databases. Drug Safety. 48(10). 1127–1139.

Cao, Xiting, James M. O’Brien, Elliot K. Fishman, et al.. (2025). Tumor localization strategies of multicancer early detection tests: a quantitative assessment. JNCI Cancer Spectrum. 9(2).

Gini, Rosa, Romin Pajouheshnia, Helga Gardarsdóttir, et al.. (2024). Describing diversity of real world data sources in pharmacoepidemiologic studies: The DIVERSE scoping review. Pharmacoepidemiology and Drug Safety. 33(5). e5787–e5787. 3 indexed citations

Durán, Carlos E., Rosa Gini, Elisa Barbieri, et al.. (2024). Incidence of severe and non-severe SARS-CoV-2 infections in children and adolescents: a population-based cohort study using six healthcare databases from Italy, Spain, and Norway. European Journal of Pediatrics. 184(1). 6–6. 1 indexed citations

Sisay, Malede Mequanent, Binyam Tilahun, Tadesse Awoke Ayele, et al.. (2023). COVID-19 Vaccine Safety Monitoring Studies in Low- and Middle-Income Countries (LMICs)—A Systematic Review of Study Designs and Methods. Vaccines. 11(6). 1035–1035. 9 indexed citations

Pereira, Leonardo, et al.. (2022). A Landscape Analysis of Post-Marketing Studies Registered in the EU PAS Register and ClinicalTrials.gov Focusing on Pregnancy Outcomes or Breastfeeding Effects: A Contribution from the ConcePTION Project. Drug Safety. 45(4). 333–344. 13 indexed citations

Durán, Carlos E., et al.. (2021). Regulatory reliance to approve new medicinal products in Latin American and Caribbean countries. Revista Panamericana de Salud Pública. 45. 1–10. 23 indexed citations

Durán, Carlos E., et al.. (2021). Potential negative impact of reputed regulators’ decisions on the approval status of new cancer drugs in Latin American countries: A descriptive analysis. PLoS ONE. 16(7). e0254585–e0254585. 4 indexed citations

Perehudoff, Katrina, et al.. (2021). Impact of the European Union on access to medicines in low- and middle-income countries: A scoping review. The Lancet Regional Health - Europe. 9. 100219–100219. 9 indexed citations

10.

Ravinetto, Raffaella, Céline Caillet, Muhammad H. Zaman, et al.. (2021). Preprints in times of COVID19: the time is ripe for agreeing on terminology and good practices. BMC Medical Ethics. 22(1). 106–106. 20 indexed citations

11.

Perehudoff, Katrina, Carlos E. Durán, Faris El‐Dahiyat, et al.. (2020). Essential Medicines in Universal Health Coverage: A Scoping Review of Public Health Law Interventions and How They Are Measured in Five Middle-Income Countries. International Journal of Environmental Research and Public Health. 17(24). 9524–9524. 8 indexed citations

12.

Guzmán, Guillermo, et al.. (2018). Diabetes de Novo Post trasplante: 20 años de experiencia en un centro de América Latina. 39(1). 7–14. 1 indexed citations

13.

Durán, Carlos E., Monique Elseviers, Robert Vander Stichele, Sylvie Rottey, & Thierry Christiaens. (2018). Sharp rise in the expenditures of targeted drugs in Ecuador: five-year (2010-2014) consumption of oncologic drugs in public and private hospitals. Journal of Pharmaceutical Health Services Research. 9(3). 175–182. 4 indexed citations

14.

Azermai, Majda, et al.. (2016). A Novel Scale Linking Potency and Dosage to Estimate Anticholinergic Exposure in Older Adults: the Muscarinic Acetylcholinergic Receptor ANTagonist Exposure Scale. Basic & Clinical Pharmacology & Toxicology. 120(6). 582–590. 30 indexed citations

15.

Elseviers, Monique, Bert Vaes, Olivia Dalleur, et al.. (2016). Anticholinergic Exposure in a Cohort of Adults Aged 80 years and Over. Basic & Clinical Pharmacology & Toxicology. 120(6). 591–600. 15 indexed citations

16.

Durán, Carlos E., Thierry Christiaens, Ángela Acosta, & Robert Vander Stichele. (2015). Systematic review of cross-national drug utilization studies in Latin America: methods and comparability. Pharmacoepidemiology and Drug Safety. 25(1). 16–25. 14 indexed citations

17.

Durán, Carlos E., Majda Azermai, & Robert Vander Stichele. (2013). Systematic review of anticholinergic risk scales in older adults. European Journal of Clinical Pharmacology. 69(7). 1485–1496. 266 indexed citations

18.

Cañas, Carlos A., et al.. (2010). Leg ulcers in the antiphospholipid syndrome may be considered as a form of pyoderma gangrenosum and they respond favorably to treatment with immunosuppression and anticoagulation. Rheumatology International. 30(9). 1253–1257. 15 indexed citations

19.

Unger, Felix, W. Gerald Rainer, Dieter Horstkotte, et al.. (2000). Standards and Concepts in Valve Surgery - A report of the task force of European Heart Institute (EHI) of the European Academy of Sciences and Arts and the International Society of Cardiothoracic Surgeons (ISCTS) -. The Thoracic and Cardiovascular Surgeon. 48(3). 175–182.

20.

Oteo, José A. & Carlos E. Durán. (1986). Performance of the lonescu-Shiley Pericardial Valve in the Aortic Position: 100 Months Clinical Experience. The Thoracic and Cardiovascular Surgeon. 34(4). 247–251. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact